Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
6.70
-0.42 (-5.90%)
At close: Oct 29, 2025, 4:00 PM EDT
6.58
-0.12 (-1.79%)
After-hours: Oct 29, 2025, 7:05 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.47 million as of October 29, 2025. Its market cap has decreased by -7.31% in one year.
Market Cap
3.47M
Enterprise Value
722.65K
1-Year Change
-7.31%
Ranking
Category
Stock Price
$6.70
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $3.47M, a decrease of -100.00%. That is a compound annual growth rate of -88.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 3.69M | 1.25% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | 135.21B | - |
| Dec 31, 2020 | 135.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.80B |
| Johnson & Johnson | 448.18B |
| AbbVie | 399.47B |
| UnitedHealth Group | 325.32B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 218.15B |